Area of research
Epidemiology · Hepatology
Research interest
Research interests include Liver Disease Diagnosis and Treatment, Liver Disease and Transplantation, Neuroendocrine Tumor Research Advances, and Liver Diseases and Immunity.
Health-related quality of life is impaired in people with autoimmune hepatitis: Results of a multicentre cross-sectional study within the European Reference Network
The future of International Classification of Diseases coding in steatotic liver disease: An expert panel Delphi consensus statement
Researchers call for more flexible editorial conduct rather than abruptly adopting only the new MASLD nomenclature
A global survey on the use of the international classification of diseases codes for metabolic dysfunction-associated fatty liver disease
Role of gut microbiota and immune cells in metabolic-associated fatty liver disease: clinical impact
Predicting survival in patients with ‘non-high-risk’ acute variceal bleeding receiving β-blockers+ligation to prevent re-bleeding
Unveiling the pathogenesis of non-alcoholic fatty liver disease by decoding biomarkers through integrated single-cell and single-nucleus profiles
Hepatic encephalopathy is not a contraindication to pre-emptive TIPS in high-risk patients with cirrhosis with variceal bleeding
Advancing the global public health agenda for NAFLD: a consensus statement
Administrative Coding in Electronic Health Care Record‐Based Research of NAFLD: An Expert Panel Consensus Statement
Bacterial infections in patients with acute variceal bleeding in the era of antibiotic prophylaxis
Macrophage Activation Markers, Soluble CD163 and Mannose Receptor, in Liver Fibrosis
Biomarkers of extracellular matrix formation are associated with acute-on-chronic liver failure
A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease
The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology
PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosis
Rebleeding and mortality risk are increased by ACLF but reduced by pre-emptive TIPS
Macrophage Activation Markers, CD163 and CD206, in Acute-on-Chronic Liver Failure
Effects of Early Placement of Transjugular Portosystemic Shunts in Patients With High-Risk Acute Variceal Bleeding: a Meta-analysis of Individual Patient Data
The Epigenetic Drug Discovery Landscape for Metabolic-associated Fatty Liver Disease
Soluble CD163 and mannose receptor as markers of liver disease severity and prognosis in patients with primary biliary cholangitis
Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF
Crosstalk between adipose tissue insulin resistance and liver macrophages in non-alcoholic fatty liver disease
Efficacy of Albumin Treatment for Patients with Cirrhosis and Infections Unrelated to Spontaneous Bacterial Peritonitis
The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
Preemptive‐TIPS Improves Outcome in High‐Risk Variceal Bleeding: An Observational Study
Orchestration of Tryptophan‐Kynurenine Pathway, Acute Decompensation, and Acute‐on‐Chronic Liver Failure in Cirrhosis
IFN-λ3, not IFN-λ4, likely mediates IFNL3–IFNL4 haplotype–dependent hepatic inflammation and fibrosis
MBOAT7 rs641738 increases risk of liver inflammation and transition to fibrosis in chronic hepatitis C